Titre : NADH, NADPH oxidoreductases

NADH, NADPH oxidoreductases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "NADH, NADPH oxidoreductases : Questions médicales les plus fréquentes", "headline": "NADH, NADPH oxidoreductases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les NADH, NADPH oxidoreductases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-05", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "NADH, NADPH oxidoreductases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxidoreductases", "url": "https://questionsmedicales.fr/mesh/D010088", "about": { "@type": "MedicalCondition", "name": "Oxidoreductases", "code": { "@type": "MedicalCode", "code": "D010088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cytochrome reductases", "alternateName": "Cytochrome Reductases", "url": "https://questionsmedicales.fr/mesh/D003579", "about": { "@type": "MedicalCondition", "name": "Cytochrome reductases", "code": { "@type": "MedicalCode", "code": "D003579", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.191" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "NADPH-ferrihemoprotéine reductase", "alternateName": "NADPH-Ferrihemoprotein Reductase", "url": "https://questionsmedicales.fr/mesh/D009251", "about": { "@type": "MedicalCondition", "name": "NADPH-ferrihemoprotéine reductase", "code": { "@type": "MedicalCode", "code": "D009251", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.191.500" } } } ] }, { "@type": "MedicalWebPage", "name": "NADH tetrazolium reductase", "alternateName": "NADH Tetrazolium Reductase", "url": "https://questionsmedicales.fr/mesh/D009246", "about": { "@type": "MedicalCondition", "name": "NADH tetrazolium reductase", "code": { "@type": "MedicalCode", "code": "D009246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.530" } } }, { "@type": "MedicalWebPage", "name": "NADP transhydrogenases", "alternateName": "NADP Transhydrogenases", "url": "https://questionsmedicales.fr/mesh/D009250", "about": { "@type": "MedicalCondition", "name": "NADP transhydrogenases", "code": { "@type": "MedicalCode", "code": "D009250", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.540" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "NADP transhydrogenase, AB-specific", "alternateName": "NADP Transhydrogenase, AB-Specific", "url": "https://questionsmedicales.fr/mesh/D061087", "about": { "@type": "MedicalCondition", "name": "NADP transhydrogenase, AB-specific", "code": { "@type": "MedicalCode", "code": "D061087", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.540.500" } } } ] }, { "@type": "MedicalWebPage", "name": "NADPH dehydrogenase", "alternateName": "NADPH Dehydrogenase", "url": "https://questionsmedicales.fr/mesh/D009252", "about": { "@type": "MedicalCondition", "name": "NADPH dehydrogenase", "code": { "@type": "MedicalCode", "code": "D009252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.550" } } }, { "@type": "MedicalWebPage", "name": "Quinone reductases", "alternateName": "Quinone Reductases", "url": "https://questionsmedicales.fr/mesh/D011808", "about": { "@type": "MedicalCondition", "name": "Quinone reductases", "code": { "@type": "MedicalCode", "code": "D011808", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "NADPH dehydrogenase (quinone)", "alternateName": "NAD(P)H Dehydrogenase (Quinone)", "url": "https://questionsmedicales.fr/mesh/D016660", "about": { "@type": "MedicalCondition", "name": "NADPH dehydrogenase (quinone)", "code": { "@type": "MedicalCode", "code": "D016660", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.800.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "NADH, NADPH oxidoreductases", "alternateName": "NADH, NADPH Oxidoreductases", "code": { "@type": "MedicalCode", "code": "D009247", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fei-Long Li", "url": "https://questionsmedicales.fr/author/Fei-Long%20Li", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China." } }, { "@type": "Person", "name": "Ye-Wang Zhang", "url": "https://questionsmedicales.fr/author/Ye-Wang%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China; College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou 535011, People's Republic of China. Electronic address: zhangyewang@ujs.edu.cn." } }, { "@type": "Person", "name": "Chuanwu Xia", "url": "https://questionsmedicales.fr/author/Chuanwu%20Xia", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA." } }, { "@type": "Person", "name": "Anna L Shen", "url": "https://questionsmedicales.fr/author/Anna%20L%20Shen", "affiliation": { "@type": "Organization", "name": "McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53706, USA." } }, { "@type": "Person", "name": "Jung-Ja P Kim", "url": "https://questionsmedicales.fr/author/Jung-Ja%20P%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. Electronic address: jjkim@mcw.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Network Meta-analysis of Different Treatments for Vestibular Migraine.", "datePublished": "2023-09-07", "url": "https://questionsmedicales.fr/article/37676473", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40263-023-01037-0" } }, { "@type": "ScholarlyArticle", "name": "Preventive Medications in Pediatric Migraine: A Network Meta-Analysis.", "datePublished": "2024-10-01", "url": "https://questionsmedicales.fr/article/39388181", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.38666" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of Laser in Hair Removal: A Network Meta-analysis.", "datePublished": "2023-07-26", "url": "https://questionsmedicales.fr/article/37493187", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/14764172.2023.2221838" } }, { "@type": "ScholarlyArticle", "name": "A network meta-analysis of arthroscopic rotator cuff repair.", "datePublished": "2023-07-13", "url": "https://questionsmedicales.fr/article/37443010", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12893-023-02078-4" } }, { "@type": "ScholarlyArticle", "name": "Treatment of children with infantile spasms: A network meta-analysis.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35765990", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dmcn.15330" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "NADH, NADPH oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D009247" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : NADH, NADPH oxidoreductases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur NADH, NADPH oxidoreductases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur NADH, NADPH oxidoreductases", "description": "Comment diagnostiquer une déficience en NADH oxydoréductases ?\nQuels tests sanguins sont utiles pour évaluer NADPH ?\nQuels symptômes indiquent un problème avec ces enzymes ?\nLes tests d'activité enzymatique sont-ils fiables ?\nPeut-on détecter des anomalies génétiques liées à ces enzymes ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Network+Meta-Analysis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur NADH, NADPH oxidoreductases", "description": "Quels sont les symptômes d'une carence en NADH ?\nComment se manifeste une déficience en NADPH ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nDes symptômes digestifs peuvent-ils apparaître ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Network+Meta-Analysis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur NADH, NADPH oxidoreductases", "description": "Comment prévenir les déficiences en NADH ?\nY a-t-il des habitudes de vie à adopter ?\nLes bilans de santé réguliers sont-ils utiles ?\nLes vaccinations peuvent-elles jouer un rôle ?\nL'éducation nutritionnelle est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Network+Meta-Analysis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur NADH, NADPH oxidoreductases", "description": "Quels traitements existent pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à réguler ces enzymes ?\nY a-t-il des traitements naturels recommandés ?\nLes transfusions sanguines sont-elles nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Network+Meta-Analysis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur NADH, NADPH oxidoreductases", "description": "Quelles complications peuvent survenir avec une déficience en NADH ?\nLes infections sont-elles une complication fréquente ?\nY a-t-il des risques de maladies chroniques ?\nLes complications cardiovasculaires sont-elles possibles ?\nDes complications hématologiques peuvent-elles survenir ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Network+Meta-Analysis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur NADH, NADPH oxidoreductases", "description": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes maladies génétiques sont-elles un facteur ?\nLe stress oxydatif joue-t-il un rôle ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Network+Meta-Analysis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en NADH oxydoréductases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être utilisés pour diagnostiquer." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles pour évaluer NADPH ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages de NADPH et d'autres coenzymes dans le sang peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec ces enzymes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, faiblesse musculaire et troubles métaboliques peuvent indiquer un problème." } }, { "@type": "Question", "name": "Les tests d'activité enzymatique sont-ils fiables ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent utilisés pour évaluer la fonction des NADH et NADPH oxydoréductases." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies génétiques liées à ces enzymes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests génétiques peuvent identifier des mutations affectant ces enzymes." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une carence en NADH ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, troubles cognitifs et faiblesse musculaire." } }, { "@type": "Question", "name": "Comment se manifeste une déficience en NADPH ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des infections fréquentes et des troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques peuvent survenir en cas de dysfonctionnement enzymatique." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général." } }, { "@type": "Question", "name": "Des symptômes digestifs peuvent-ils apparaître ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles digestifs peuvent être liés à des anomalies dans le métabolisme énergétique." } }, { "@type": "Question", "name": "Comment prévenir les déficiences en NADH ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en nutriments essentiels peut aider à prévenir ces déficiences." } }, { "@type": "Question", "name": "Y a-t-il des habitudes de vie à adopter ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain incluant exercice et gestion du stress est recommandé." } }, { "@type": "Question", "name": "Les bilans de santé réguliers sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent aider à détecter précocement des anomalies enzymatiques." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles jouer un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les déficiences." } }, { "@type": "Question", "name": "L'éducation nutritionnelle est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre l'importance des nutriments peut aider à prévenir les carences." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique est explorée pour traiter certaines déficiences enzymatiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler ces enzymes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent aider à moduler l'activité des NADH et NADPH oxydoréductases." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des antioxydants et des nutriments peuvent soutenir la fonction enzymatique." } }, { "@type": "Question", "name": "Les transfusions sanguines sont-elles nécessaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas graves, des transfusions peuvent être nécessaires pour corriger des déficiences." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déficience en NADH ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques." } }, { "@type": "Question", "name": "Les infections sont-elles une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des déficiences enzymatiques sont plus susceptibles aux infections." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies chroniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déficiences peuvent augmenter le risque de maladies chroniques comme le diabète." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles métaboliques peuvent entraîner des complications cardiovasculaires." } }, { "@type": "Question", "name": "Des complications hématologiques peuvent-elles survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans le métabolisme peuvent entraîner des complications hématologiques." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et une mauvaise nutrition." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines déficiences peuvent être plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques prédisposent aux déficiences en NADH et NADPH." } }, { "@type": "Question", "name": "Le stress oxydatif joue-t-il un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut aggraver les déficiences enzymatiques et leurs effets." } } ] } ] }

Sources (10000 au total)

Network Meta-analysis of Different Treatments for Vestibular Migraine.

Although one of the major presentations of vestibular migraine is dizziness with/without unsteady gait, it is still classified as one of the migraine categories. However, in contrast to ordinary migra... The objective of this current network meta-analysis (NMA) was to compare the efficacy and acceptability of individual treatment strategies in patients with vestibular migraine.... The PubMed, Embase, ScienceDirect, ProQuest, Web of Science, ClinicalKey, Cochrane Central, and ClinicalTrials.gov databases were systematically searched for randomized controlled trials (RCTs), with ... Seven randomized controlled trials (N = 828, mean age 37.6 years, 78.4% female) and seven active regimens were included. We determined that only valproic acid (standardized mean difference [SMD] -1.61... The current study provides evidence that only valproic acid, propranolol, and venlafaxine might be associated with beneficial efficacy in vestibular migraine treatment.... CRD42023388343....

Preventive Medications in Pediatric Migraine: A Network Meta-Analysis.

Pediatric migraine substantially impacts quality of life and academic performance among children and adolescents. Understanding the efficacy and safety of pharmacological interventions for migraine pr... To conduct a comprehensive network meta-analysis to evaluate the efficacy and safety associated with pharmacological treatments for pediatric migraine prophylaxis among pediatric patients with a migra... PubMed, Embase, and SCOPUS were searched for publications up to September 2023. Search terms and indexing were chosen to encompass relevant studies, focusing on randomized clinical trials in pediatric... Inclusion criteria targeted randomized clinical trials involving pediatric patients with migraine. Studies were selected based on their examination of oral pharmacological interventions. The search yi... Data extraction adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines. Five investigators independently extracted study data into a spreadsheet in duplicat... The primary outcome was migraine frequency (number of attacks per month). Secondary outcomes included a 50% or greater responder rate, headache duration, headache intensity, and disability (assessed b... The analysis incorporated 45 trials with 3771 participants. Compared with placebo, pregabalin (ratio of means [RoM], 0.38; 95% CI, 0.18-0.79) and topiramate with vitamin D3 (RoM, 0.44; 95% CI, 0.30-0.... In this network meta-analysis of randomized clinical trials, topiramate and pregabalin were associated with reduction in headache frequency and intensity. Although there were also other drugs that sho...

Efficacy of Laser in Hair Removal: A Network Meta-analysis.

Laser hair removal is an increasingly prevalent trend of cosmetic procedures. The purpose of this study was to assess the effectiveness of hair reduction among several types of laser interventions.... The selected studies searched in PubMed and EMBASE were assessed for quality of evidence, and extracted data on absolute hair count and hair reduction rate. Qualitative data were synthesized using sta... A total of 13 randomized controlled trials (RCTs) (... Eliminating unwanted hair with lasers or intense pulsed light is safe and effective; however, which type of intervention is more beneficial in the long-term process should be studied with a longer fol...

A network meta-analysis of arthroscopic rotator cuff repair.

Rotator cuff tear is a common shoulder injury that often leads to serious limitations in daily life. Herein, a network Meta-analysis using frequency theory was performed to evaluate the clinical outco... PubMed, EMbase, The Cochrane Library, and Web of Science were searched for randomized controlled trials and cohort studies comparing rotator cuff repair techniques published from inception to May 2022... A total of 51 articles were finally included, including 27 randomized controlled trials and 24 cohort studies. Results from the network Meta-analysis showed that: (1) In terms of the American Shoulder... Based on the results of network Meta-analysis and surface under the cumulative ranking, platelet-rich plasma therapy, bone marrow stimulation, and double-row repair have good overall rehabilitation ef...

Treatment of children with infantile spasms: A network meta-analysis.

We performed a systematic review and network meta-analysis (NMA) to obtain comparative effectiveness estimates and rankings of non-surgical interventions used to treat infantile spasms.... All randomized controlled trials (RCTs) including children 2 months to 3 years of age with infantile spasms (with hypsarrhythmia or hypsarrhythmia variants on electroencephalography) receiving appropr... Twenty-two RCTs comparing first-line treatments for infantile spasms were reviewed; of these, 17 were included in the NMA. Both frequentist and Bayesian network rankings for electroclinical remission ... Treatments including ACTH and high dose prednisolone are more effective in achieving electroclinical and clinical remissions for infantile spasms.... Adrenocorticotropic hormone and high dose prednisolone are more effective than other medications for infantile spasms. Symptomatic etiology decreases the likelihood of remission even after adjusting f...

Comparison of interventions for Barrett's esophagus: A network meta-analysis.

Barrett's esophagus (BE) is a precancerous condition that has the potential to develop into esophageal cancer (EC). Currently, there is a wide range of management options available for individuals at ... Data extracted from eligible randomized controlled trials were utilized in a Bayesian network meta-analysis to examine the relative effectiveness of BE's treatment regimens and determine their ranking... We identified twenty-three RCT studies with a total of 1675 participants, and ten different interventions. Regarding complete ablation of non-dysplastic BE, the comparative effectiveness ranking indic... Endoscopic surveillance alone or PPI/H2RA alone may not be sufficient for managing BE, even in cases of non-dysplastic BE. However, APC has shown excellent efficacy in treating non-dysplastic BE. For ...

Treatment of diabetic kidney disease. A network meta-analysis.

Diabetic kidney disease (DKD) is a health burden of rising importance. Slowing progression to end stage kidney disease is the main goal of drug treatment. The aim of this analysis is to compare drug t... We searched Medline, CENTRAL and clinicaltrials.gov for randomized, controlled studies including adults with DKD treated with the following drugs of interest: single angiotensin-converting-enzyme-inhi... Of initial 3489 publications, 38 clinical trials were found eligible, in total including 42346 patients. Concerning the primary endpoints overall mortality and end stage kidney disease, SGLT2i on top ... As the only drug class, SGLT2i showed in our analysis beneficial effects on top of ACEi/ARB treatment regarding mortality and end stage kidney disease and by that reconfirmed its position as treatment...

Pharmaceutical Therapies for the Treatment of Obesity: A Network Meta-analysis.

Despite the introduction of various pharmaceutical therapies for treating obesity, selecting the optimal treatment remains challenging for both patients and physicians. Therefore, in this network meta... International databases, including PubMed, Web of Science, Scopus, Cochrane Library, and Embase, were searched for studies published from database inception to April 2023. The consistency assumption w... Of 9519 retrieved references, 96 randomized controlled trials, including 68 with both men and women, 23 with women only, and 5 with men only, met the eligibility criteria for this study. There were 4 ... According to the results of this NMA, semaglutide seems to be an effective treatment option for both men and women, whereas beloranib appears to be particularly effective for women with obesity and ov...

Model selection for component network meta-analysis in connected and disconnected networks: a simulation study.

Network meta-analysis (NMA) allows estimating and ranking the effects of several interventions for a clinical condition. Component network meta-analysis (CNMA) is an extension of NMA which considers t... We evaluate a forward model selection strategy for component network meta-analysis to relax the additivity assumption that can be used in connected or disconnected networks. In addition, we describe a... CNMA models provide good performance for connected networks and can be an alternative to standard NMA if additivity holds. For disconnected networks, we recommend to use additive CNMA only if strong c... CNMA methods are feasible for connected networks but questionable for disconnected networks....